Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Amicus Therapeutics, Inc.
About FOLD
Amicus Therapeutics, Inc. is a global biotechnology company focused on discovering, developing and delivering medicines for people living with rare diseases. Its two marketed therapies are Galafold, the first oral monotherapy for people living with Fabry disease who have amenable genetic variants, and Pombiliti + Opfolda, a two-component treatment for adults living with late-onset Pompe disease. As an orally miglustat monotherapy, Galafold is designed to bind to and stabilize an endogenous alpha-galactosidase A enzyme in those patients with genetic variants identified as amenable in a Good Laboratory Practice cell-based amenability assay. Pombiliti + Opfolda consists of an engineered rhGAA enzyme, cipaglucosidase alfa-atga, with an optimized carbohydrate structure to enhance cellular uptake, administered intravenously in combination with orally administered miglustat. In addition, clinical studies are ongoing in pediatric patients for both the LOPD and IOPD populations.
Find out what a historical investment in Amicus Therapeutics, Inc. would be worth today using our FOLD stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy FOLD shares in Australia?
Buying FOLD shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Amicus Therapeutics, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in FOLD
What is the ticker symbol of Amicus Therapeutics, Inc.?
The ticker symbol for Amicus Therapeutics, Inc. is FOLD.
How much is one share of FOLD?
One share of FOLD is valued at $14.49 as of 21 May 2026.
What is the market capitalisation of Amicus Therapeutics, Inc. FOLD?
As of 21 May 2026 Amicus Therapeutics, Inc. has a market cap of -.
What is the 52-week high for Amicus Therapeutics, Inc. stock?
The Amicus Therapeutics, Inc. 52-week high stock price is $NaN.
What is the 52-week low for Amicus Therapeutics, Inc. stock?
The Amicus Therapeutics, Inc. 52-week low stock price is $NaN.
Can I buy FOLD shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy FOLD shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in FOLD on Stake
- Buy FOLD from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of FOLD from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
FOLD related stocks